Improved results from filler injection procedures and emerging use of injection adipolysis are expected to positively alter the growth of global market for facial rejuvenation.
Cosmetic treatments will soon endure an overriding status among several healthcare facilities that are predominantly availed by millions of people. Revamping their appearance renders higher demand for incorporating advanced medical procedures in cosmetic treatments. Among such treatments, facial rejuvenation has gained prominence and surgical and non-invasive measures are being actively used to treat facial irregularities such as skin laxity, scars, wrinkles and hyperpigmentation. The need for facial rejuvenation isn’t constrained to the females, as a considerable number of men are actively adopting facial rejuvenation treatments, particularly the ones who are constantly in the public eye.
The global market for facial rejuvenation is projected to attain market value of US$ 26.5 billion by 2021, according to a report compiled by Persistence Market Research, titled “Global Market Study on Facial Rejuvenation: Early Onset of Ageing & Rising Adoption of Minimally Invasive Procedures to Drive the Market.” Lifestyle choices made by people are the primary drivers for the global facial rejuvenation market. Ageing is the underlying driver for growth in demand for facial rejuvenation procedures as a significant proportion of global geriatric population tends to use them in their early 70s. But, the global facial rejuvenation market continues to be spooked by the prolonging consumer skepticism due to the lack of documented evidences for the effectiveness of such cosmetic procedures.
Injectable adipolysis is a recent advancement in cosmetic procedures used for facial rejuvenation that is expected to garner mixed responses. The inclusion of injectable adipolysis in facial-neck rejuvenation is slated to influence consumers towards adoption of combination cosmetic procedures. Optimal outcomes expected from facial rejuvenation programs are also stimulating the use of filler injections such as neuromodulators that are injected in the forehead frontalis for reshaping and raise the eyebrows.
In 2014, the global market was valued at US$ 18 billion. Assessment of the growth in global facial rejuvenation market can be fragmented on the basis of types of products and end-users. Laser surfacing treatments, chemical peels, botulinum, topical products, dermal fillers, and microabrasion equipment, are the key product-types segmented in the global facial rejuvenation market. Botulinum products, amidst these, are projected to account for over 35% share of the global market throughout the forecast period. Hospitals and dermatology clinics are the prominent end-users influencing the growth of global facial rejuvenation market, with the latter being a dominant segment for treatment advising and drugs prescription.
By the end of 2021, the facial rejuvenation market in North America will dominate globally by accounting to over 30% of the overall global market. Asia and Latin America are slated to register fastest growth in their facial rejuvenation market with botulinum products being the foremost revenue contributor. Rising popularity of combination cosmetic treatments is also fostering the growth of facial rejuvenation market in such regions. Biopolymer GmbH &Co KG, Gal derma S/A, Anika Therapeutics, Inc., Speciality European Pharma, LUMENIS, Mentor Worldwide LLC, Revance Therapeutics, Inc., Fibrocell, Inc., Cynosure, Inc., Merz GmbH & Co. KGaA, and Contura International A/S, among others, are observed to be the leading companies participating in the global market for facial rejuvenation.
Request and Download Sample Report@ https://www.persistencemarketresearch.com/samples/3639